FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Disopyramide Phosphate (Norpace) Capsules
Status: Currently in Shortage
»Date first posted: 03/19/2021
»Therapeutic Categories: Cardiovascular

Expand all

Pfizer Pharmaceuticals (Revised 10/08/2021)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Norpace CR, 100 mg capsules, bottle of 100 (NDC 0025-2732-31) Next Delivery and Estimated Recovery: January 2022 Manufacturing Delay. Please contact Pfizer Customer Service for assistance. Other
Norpace CR, 150 mg capsules, bottle of 100 (NDC 0025-2742-31) Next Delivery and Estimated Recovery: January 2022 Manufacturing Delay. Please contact Pfizer Customer Service for assistance. Other
100 mg capsules, bottle of 100 (NDC 59762-0386-1) Next Delivery: November 2021; Estimated Recovery: March 2022 Shortage per Manufacturer: Manufacturing delay Other
150 mg capsules, bottle of 100 (NDC 59762-0400-1) Next Delivery and Estimated Recovery: February 2022 Greenstone label
Norpace IR, 100 mg capsules; bottle of 100 (NDC 0025-2752-31) Next Delivery and Estimated Recovery: Q1 2022 Shortage per Manufacturer: Manufacturing delay Other
Norpace IR, 150 mg capsules; bottle of 100 (NDC 0025-2762-31) Available

Teva Pharmaceuticals (Reverified 10/07/2021)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg capsules, bottle of 100 (NDC 0093-3127-01) Available
150 mg capsules, bottle of 100 (NDC 0093-3129-01) Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English